VSee Health, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
VSee Health, Inc. (VSEE) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $224.97 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-14
- VSee Health, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $380.03K, a 1958.99% increase year-over-year.
- VSee Health, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$155.06K, a 122.39% decline year-over-year.
- VSee Health, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $878.09K.
- VSee Health, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $2.65M, a 133.31% increase year-over-year.
- VSee Health, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $4.24M.
- VSee Health, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was -$1.45M, a 202.59% decline from fiscal 2023.
- VSee Health, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $1.41M, a 19.26% decline from fiscal 2022.
- VSee Health, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $1.75M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $380.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $224.97K 10-Q · filed 2026-08-14 | $1.10M derived: sum of 3 quarters · filed 2026-08-14 | $3.75M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | -$155.06K 10-Q · filed 2026-05-15 | $723.03K derived: sum of 2 quarters · filed 2026-05-15 | $3.37M derived: sum of 3 quarters · filed 2026-05-15 | $3.39M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $878.09K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $3.52M derived: sum of 2 quarters · filed 2026-03-31 | $3.54M derived: sum of 3 quarters · filed 2026-08-14 | $4.24M 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $2.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $2.67M derived: sum of 2 quarters · filed 2026-08-14 | $3.36M 10-Q · filed 2025-11-14 | $3.10M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $18.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $711.04K 10-Q · filed 2026-08-14 | $951.80K 10-Q · filed 2025-10-15 | $448.48K derived: sum of 3 quarters · filed 2026-08-14 | $1.58M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $692.59K 10-Q · filed 2026-05-15 | $430.02K derived: sum of 2 quarters · filed 2026-05-15 | $1.56M derived: sum of 3 quarters · filed 2026-05-15 | -$808.24K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | -$262.56K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $871.89K derived: sum of 2 quarters · filed 2026-03-31 | -$1.50M derived: sum of 3 quarters · filed 2026-03-31 | -$1.45M 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | $1.13M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-11-14 | -$1.24M derived: sum of 2 quarters · filed 2025-11-20 | -$1.18M 10-Q · filed 2025-11-14 | -$161.97K 10-Q · filed 2024-11-14 | -$942.59K derived: sum of 4 quarters · filed 2025-11-20 | |||
| 2024-06-30 | -$2.37M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2025-11-20 | -$2.32M 10-Q/A · filed 2025-11-20 | -$1.58M 10-Q · filed 2024-09-23 | -$2.08M derived: sum of 3 quarters · filed 2025-11-20 | -$1.96M derived: sum of 4 quarters · filed 2025-11-20 | |||
| 2024-03-31 | $54.52K 10-Q · filed 2025-10-15 | $338.94K 10-Q · filed 2024-05-15 | $295.67K derived: sum of 2 quarters · filed 2025-10-15 | $412.71K derived: sum of 3 quarters · filed 2025-10-15 | $1.41M derived: sum of 4 quarters · filed 2025-10-15 | |||
| 2023-12-31 | $241.15K derived: 10-K/A 12 month − 10-K/A 9 month · filed 2025-08-29 | $358.19K derived: sum of 2 quarters · filed 2025-08-29 | $1.35M derived: sum of 3 quarters · filed 2025-08-29 | $1.41M 10-K/A · filed 2025-08-29 | $1.63M 10-K · filed 2024-04-12 | |||
| 2023-09-30 | $117.05K derived: 10-K/A 9 month − 10-K/A 6 month · filed 2025-08-29 | $1.11M derived: sum of 2 quarters · filed 2025-08-29 | $1.17M 10-K/A · filed 2025-08-29 | $957.99K 10-Q · filed 2023-11-20 | $1.63M derived: sum of 4 quarters · filed 2025-08-29 | |||
| 2023-06-30 | $996.57K derived: 10-K/A 6 month − 10-K/A 3 month · filed 2025-08-29 | $1.05M 10-K/A · filed 2025-08-29 | $507.26K 10-Q · filed 2023-08-21 | $1.52M derived: sum of 3 quarters · filed 2025-08-29 | $2.35M derived: sum of 4 quarters · filed 2025-08-29 | |||
| 2023-03-31 | $55.06K 10-K/A · filed 2025-08-29 | $419.42K 10-Q · filed 2023-05-15 | $518.78K derived: sum of 2 quarters · filed 2025-08-29 | $1.35M derived: sum of 3 quarters · filed 2025-08-29 | $1.60M derived: sum of 4 quarters · filed 2025-08-29 | |||
| 2022-12-31 | $463.72K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-12 | $1.29M derived: sum of 2 quarters · filed 2024-04-12 | $1.54M derived: sum of 3 quarters · filed 2024-04-12 | $1.75M 10-K · filed 2024-04-12 | ||||
| 2022-09-30 | $830.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | $1.08M derived: sum of 2 quarters · filed 2023-11-20 | $1.28M 10-Q · filed 2023-11-20 | |||||
| 2022-06-30 | $249.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | $451.92K 10-Q · filed 2023-08-21 | ||||||
| 2022-03-31 | $202.30K 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | $140.16K 10-K · filed 2023-04-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |